Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Cash from Operations (2022 - 2025)

Historic Cash from Operations for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$900000.0.

  • PAVmed's Cash from Operations changed N/A to -$900000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.7 million, marking a year-over-year change of. This contributed to the annual value of -$33.6 million for FY2024, which is 3542.93% up from last year.
  • Per PAVmed's latest filing, its Cash from Operations stood at -$900000.0 for Q3 2025.
  • Over the past 5 years, PAVmed's Cash from Operations peaked at $48000.0 during Q4 2024, and registered a low of -$22.6 million during Q2 2022.
  • Moreover, its 4-year median value for Cash from Operations was -$12.1 million (2022), whereas its average is -$10.8 million.
  • As far as peak fluctuations go, PAVmed's Cash from Operations plummeted by 3342.58% in 2023, and later soared by 10040.42% in 2024.
  • Over the past 4 years, PAVmed's Cash from Operations (Quarter) stood at -$16.8 million in 2022, then increased by 29.42% to -$11.9 million in 2023, then skyrocketed by 100.4% to $48000.0 in 2024, then tumbled by 1975.0% to -$900000.0 in 2025.
  • Its Cash from Operations was -$900000.0 in Q3 2025, compared to -$1.2 million in Q2 2025 and -$1.6 million in Q1 2025.